The costimulatory signaling of CD58 facilitates CTL activation, proliferation, and cytotoxicity [14], while CD58 loss may contribute to a reduction in the recognition and adhesion of T/NK cells to tumor cells in tumor microenvironment [20]. This evidence concerns the gene CD58 and neoplasm.